Circuit Therapeutics Inc.

Having "already achieved important milestones" in a first deal with Gubra ApS signed less than two years ago, Boehringer Ingelheim GmbH has entered into a second obesity collaboration with the Dan

In an exclusive interview with Scrip at the BIO-Europe partnering conference in Berlin, Nov. 6-8, Klaus Mendla, Boehringer Ingelheim GMBH's global head of business development and licensing, CNS,

IN VITRO DIAGNOSTICS ALLIANCES Akers Biosciences Inc. Alere Inc. First Check Diagnostics LLC Akers Biosciences Inc. licensed Alere Inc. 's First Check Diagnostics LLC exclusive US distribut

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Dec. 12-23. Deal Wat